COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
25/12/2024
Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 [...]
CorVel Announces Effectiveness of Three-For-One Forward Stock Split
24/12/2024
FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced the effectiveness of a three-for-one forward stock split, along with a proportionate increase in the number of [...]
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
24/12/2024
- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - LONDON, Dec. 24, 2024 (GLOBE [...]
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan
24/12/2024
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today [...]
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
24/12/2024
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
24/12/2024
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
24/12/2024
Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Patent Tech-AI Law NGO serving disabled people who can't afford attorney (Quantum computers meets law sector): VRN News
24/12/2024
P2P virtual law clinic aiding disabled veterans in legal actions may be the first AI-powered attorney network licensed in nearly every jurisdiction CAMBRIDGE, Mass., Dec. 24, 2024 (GLOBE NEWSWIRE) -- Earlier this month [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
24/12/2024
Déclaration de transactions sur actions propres Paris, France (24 décembre 2024, 8h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 17 décembre 2024 [...]
Aster Guardians Global Nursing Award 2025 worth US$250,000 now open for nominations worldwide
24/12/2024
Registered nurses from across the world can submit their applications through www.asterguardians.com in their preferred languages by February 10, 2025 . DUBAI, United Arab Emirates, Dec. 24, 2024 (GLOBE NEWSWIRE) -- [...]
XBiotech suspend son programme de rhumatologie
24/12/2024
Des résultats de l’étude sur la polyarthrite rhumatoïde récemment conduite soulèvent des questions AUSTIN, Texas, 24 déc. 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui qu’elle suspendait son [...]
PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million
24/12/2024
• 630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025; • Upon Potential Positive Phase 3 Data the Company Expects to Submit a New Drug Application (“ [...]
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq
23/12/2024
BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“ Neuphoria ” or the “ Company ”) is pleased to announce that its previously announced scheme of arrangement in relation [...]
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 43 rd Annual J.P. Morgan [...]
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43 rd Annual J.P. Morgan [...]
Solid Biosciences Added to the Nasdaq Biotechnology Index
23/12/2024
CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
23/12/2024
WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
Abivax Announces a Change to the Composition of its Board of Directors
23/12/2024
Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]

Pages